Immunization with GP1 but not core-like particles displaying isolated receptor-binding epitopes elicits virus-neutralizing antibodies against junín virus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Vaccines ; 10 (2022), 2. - Art.-Nr. 173. - eISSN 2076-393X
- Keyword
-
Arenaviren
Immunreaktion
Glykoproteine
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2022
- Creator
-
Roman-Sosa, Gleyder
Leske, Anne
Ficht, Xenia
Dau, Tung Huy
Holzerland, Julia
Hoenen, Thomas
Beer, Martin
Kammerer, Robert
Schirmbeck, Reinhold
Rey, Felix A.
Cordo, Sandra M.
Groseth, Allison
- DOI
-
10.18725/OPARU-50328
- URN
-
urn:nbn:de:bsz:289-oparu-50404-0
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:49 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Roman-Sosa, Gleyder
- Leske, Anne
- Ficht, Xenia
- Dau, Tung Huy
- Holzerland, Julia
- Hoenen, Thomas
- Beer, Martin
- Kammerer, Robert
- Schirmbeck, Reinhold
- Rey, Felix A.
- Cordo, Sandra M.
- Groseth, Allison
- Universität Ulm
Time of origin
- 2022
Other Objects (12)
Human hepatitis D virus-specific T cell epitopes
Development of neutralizing and non-neutralizing antibodies targeting known and novel epitopes on Clostridioides difficile Toxin B
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Characterization of JC virus-specific CD4+ T cell epitopes in healthy individuals
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Identification of HIV-1 neutralizing antibodies and their epitopes from elite controllers by phage display
Retracted: Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Characterization of the Alfalfa Mosaic Virus as expression, presentation, delivery and screening system for potential epitopes derived from the Respiratory Syncytial Virus Fusion Protein
Human hepatitis D virus-specific T cell epitopes
Development of neutralizing and non-neutralizing antibodies targeting known and novel epitopes on Clostridioides difficile Toxin B
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Characterization of JC virus-specific CD4+ T cell epitopes in healthy individuals
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Identification of HIV-1 neutralizing antibodies and their epitopes from elite controllers by phage display
Retracted: Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Characterization of the Alfalfa Mosaic Virus as expression, presentation, delivery and screening system for potential epitopes derived from the Respiratory Syncytial Virus Fusion Protein
Human hepatitis D virus-specific T cell epitopes
Development of neutralizing and non-neutralizing antibodies targeting known and novel epitopes on Clostridioides difficile Toxin B
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Characterization of JC virus-specific CD4+ T cell epitopes in healthy individuals
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Identification of HIV-1 neutralizing antibodies and their epitopes from elite controllers by phage display
Retracted: Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies